Netherlands-based artificial intelligence (AI) startup Aidence, a company that is bringing the full potential of AI into the hands of medical professionals in medical imaging and disease detection, has recently secured a funding of €10 million. The round was led by INKEF Capital and co-investor Rabo Ventures, alongside existing investors Northzone, HenQ and Health Innovations. This investment brings Aidence’s total funding to €12.5 million.
Applying AI to analyse chest CT scans for lung cancer
Founded in 2015, the Amsterdam-based company has placed its emphasis on the early recognition of lung cancer by applying AI algorithms to medical imaging. The startup has come up with a solution known as Veye Chest, which is believed to assist radiologists to diagnose and track developments in pulmonary nodules, in order to determine lung cancer.